The Eliassen Group Biometrics and Data Solutions team will be attending the upcoming International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting from May 21-25 in Washington, DC. The theme for this year’s event is, “Value, Affordability, and Patient Centeredness: Can We Have it All?” Sessions will include:
- “Accelerating Cures: Addressing Unmet Patient Need or Putting Patients at Risk?” debating the benefits and dangers of an accelerated approval process.
- “Making Medical Decisions in an Irrational World” will focus on behavioral economics related to patient choice and allocation decisions.
- Hear from the FDA on “Contemporary Regulatory and Legislative Issues in Health Outcomes Research.”
Eliassen Group's own Eros Papademetriou, Manager of Outcomes Research, will conduct a poster presentation on Monday, May 23rd between 8:30AM and 2:00PM with author discussion from 1:00 -2:00PM. Here is an overview of the session:
DIFFERENTIAL ACCESS TO CARE BETWEEN DEPRESSED AND NON-DEPRESSED CHILDREN IN A PATIENT CENTERED MEDICAL HOME
Given the growth of Patient Centered Medical Homes (PCMH) in the past decade, Eliassen outcomes researchers were interested in whether this model of care is beneficial for children diagnosed with depression. The PCMH is a model of care that strives to deliver high quality primary care by creating a structure of health care coordination between the patient/family, primary physician, specialist physicians, and the community. We used the 2011-2012 National Survey of Children’s Health to explore our question. Our findings suggest that while the PCMH model does have a positive effect on primary and specialty care access for depressed children, more work needs to be done to reduce the burden of seeking needed care.
If you’re interested in learning more about these topics, please feel free to reach out to us so that we can schedule a time to meet with you at the conference: email@example.com. We look forward to seeing you there!